353 related articles for article (PubMed ID: 18279484)
1. Clinical proteomics in neurodegenerative disorders.
Zetterberg H; Rüetschi U; Portelius E; Brinkmalm G; Andreasson U; Blennow K; Brinkmalm A
Acta Neurol Scand; 2008 Jul; 118(1):1-11. PubMed ID: 18279484
[TBL] [Abstract][Full Text] [Related]
2. Proteomics in neurosciences.
Drabik A; Bierczynska-Krzysik A; Bodzon-Kulakowska A; Suder P; Kotlinska J; Silberring J
Mass Spectrom Rev; 2007; 26(3):432-50. PubMed ID: 17405153
[TBL] [Abstract][Full Text] [Related]
3. Biomarkers for Alzheimer's disease and other forms of dementia: clinical needs, limitations and future aspects.
Cedazo-Minguez A; Winblad B
Exp Gerontol; 2010 Jan; 45(1):5-14. PubMed ID: 19796673
[TBL] [Abstract][Full Text] [Related]
4. 2D gel blood serum biomarkers reveal differential clinical proteomics of the neurodegenerative diseases.
Sheta EA; Appel SH; Goldknopf IL
Expert Rev Proteomics; 2006 Feb; 3(1):45-62. PubMed ID: 16445350
[TBL] [Abstract][Full Text] [Related]
5. [CSF biomarkers: proteomics investigations and clinical applications in neurodegenerative disorders].
Gabelle A; Roche S; Lehmann S
Rev Neurol (Paris); 2009 Mar; 165(3):213-22. PubMed ID: 18808768
[TBL] [Abstract][Full Text] [Related]
6. Biomarkers of neurodegenerative disorders: how good are they?
Rachakonda V; Pan TH; LE WD
Cell Res; 2004 Oct; 14(5):347-58. PubMed ID: 15538967
[TBL] [Abstract][Full Text] [Related]
7. Neuroproteomics tools in clinical practice.
Shevchenko G; Konzer A; Musunuri S; Bergquist J
Biochim Biophys Acta; 2015 Jul; 1854(7):705-17. PubMed ID: 25680928
[TBL] [Abstract][Full Text] [Related]
8. Neurochemical approaches of cerebrospinal fluid diagnostics in neurodegenerative diseases.
Otto M; Lewczuk P; Wiltfang J
Methods; 2008 Apr; 44(4):289-98. PubMed ID: 18374272
[TBL] [Abstract][Full Text] [Related]
9. Functional Genomics meets neurodegenerative disorders. Part II: application and data integration.
Hoerndli F; David DC; Götz J
Prog Neurobiol; 2005 Jun; 76(3):169-88. PubMed ID: 16169146
[TBL] [Abstract][Full Text] [Related]
10. Clinical perspectives of high-resolution mass spectrometry-based proteomics in neuroscience: exemplified in amyotrophic lateral sclerosis biomarker discovery research.
Ekegren T; Hanrieder J; Bergquist J
J Mass Spectrom; 2008 May; 43(5):559-71. PubMed ID: 18416436
[TBL] [Abstract][Full Text] [Related]
11. Looking backward to move forward: early detection of neurodegenerative disorders.
DeKosky ST; Marek K
Science; 2003 Oct; 302(5646):830-4. PubMed ID: 14593169
[TBL] [Abstract][Full Text] [Related]
12. From proteomics to biomarker discovery in Alzheimer's disease.
Ho L; Sharma N; Blackman L; Festa E; Reddy G; Pasinetti GM
Brain Res Brain Res Rev; 2005 Apr; 48(2):360-9. PubMed ID: 15850675
[TBL] [Abstract][Full Text] [Related]
13. High-field magnetic resonance imaging of brain iron: birth of a biomarker?
Schenck JF; Zimmerman EA
NMR Biomed; 2004 Nov; 17(7):433-45. PubMed ID: 15523705
[TBL] [Abstract][Full Text] [Related]
14. Plasma biomarkers for mild cognitive impairment and Alzheimer's disease.
Song F; Poljak A; Smythe GA; Sachdev P
Brain Res Rev; 2009 Oct; 61(2):69-80. PubMed ID: 19464319
[TBL] [Abstract][Full Text] [Related]
15. What is 'early onset dementia'?
Miyoshi K
Psychogeriatrics; 2009 Jun; 9(2):67-72. PubMed ID: 19604328
[TBL] [Abstract][Full Text] [Related]
16. Serum biomarkers for Alzheimer's disease: proteomic discovery.
German DC; Gurnani P; Nandi A; Garner HR; Fisher W; Diaz-Arrastia R; O'Suilleabhain P; Rosenblatt KP
Biomed Pharmacother; 2007 Aug; 61(7):383-9. PubMed ID: 17614251
[TBL] [Abstract][Full Text] [Related]
17. Proteomics of brain extracellular fluid (ECF) and cerebrospinal fluid (CSF).
Maurer MH
Mass Spectrom Rev; 2010; 29(1):17-28. PubMed ID: 19116946
[TBL] [Abstract][Full Text] [Related]
18. Differential diagnosis of neurodegenerative diseases with special emphasis on Creutzfeldt-Jakob disease.
Otto M; Wiltfang J
Restor Neurol Neurosci; 2003; 21(3-4):191-209. PubMed ID: 14530581
[TBL] [Abstract][Full Text] [Related]
19. Oxidative stress and neurotoxicity.
Sayre LM; Perry G; Smith MA
Chem Res Toxicol; 2008 Jan; 21(1):172-88. PubMed ID: 18052107
[TBL] [Abstract][Full Text] [Related]
20. Cellular pathways leading to neuronal dysfunction and degeneration.
Kazantsev AG
Drug News Perspect; 2007 Oct; 20(8):501-9. PubMed ID: 18080037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
